Capstar Special Acquisition Corp Cl A (CPSR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CPSR | PSTX | FATE | ||
| Company | Capstar Special Acquisition Corp Cl A | Poseida Therapeutics Inc | Fate Therapeutics | ||
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | ||
| Open | 6.29 | 2.75 | 2.23 | ||
| High | 7.48 | 2.81 | 2.28 | ||
| Low | 6.28 | 2.65 | 2.01 | ||
| Last | 7.36 | 2.71 | 2.07 | ||
| Change | +0.66 | -0.01 | -0.15 | ||
| % Change | +9.85% | -0.37% | -6.76% | ||
| Volume | 226,000 | 297,600 | 2,009,000 | ||
| 20-Day Average Volume | 358,240 | 550,945 | 3,009,835 | ||
| Previous Close | 6.70 | 2.72 | 2.22 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 9.51 | 2.80 | 2.43 | ||
| 20-Day Raw Stochastic | 21.07% | 25.66% | 7.14% | ||
| 20-Day Relative Strength | 21.85% | 47.89% | 36.95% | ||
| Weighted Alpha | -31.79 | -25.25 | -51.71 | ||
| Today's Opinion | 88% Sell | 72% Sell | 100% Sell | ||
| Previous Opinion | 88% Sell | 88% Sell | 100% Sell | ||
| Last Month's Opinion | 32% Buy | 100% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -25.92% since 01/06/22 | -15.58% since 11/14/24 | -0.48% since 11/14/24 | ||
| Low | 6.06 on 01/12/22 | 2.63 on 11/20/24 | 1.96 on 11/15/24 | ||
| High | 12.23 on 01/10/22 | 3.28 on 11/15/24 | 3.50 on 11/18/24 | ||
| 1-Month | |||||
| %Chg | -25.96% since 12/13/21 | +8.40% since 10/21/24 | -34.29% since 10/21/24 | ||
| Low | 6.06 on 01/12/22 | 2.32 on 10/31/24 | 1.96 on 11/15/24 | ||
| High | 12.23 on 01/10/22 | 3.84 on 11/12/24 | 3.50 on 11/18/24 | ||
| 3-Month | |||||
| %Chg | -26.33% since 10/13/21 | -6.87% since 08/21/24 | -47.06% since 08/21/24 | ||
| Low | 6.06 on 01/12/22 | 2.32 on 10/31/24 | 1.96 on 11/15/24 | ||
| High | 12.23 on 01/10/22 | 3.92 on 09/18/24 | 4.20 on 09/19/24 | ||
| 6-Month | |||||
| %Chg | -24.90% since 07/13/21 | -8.75% since 05/21/24 | -44.05% since 05/21/24 | ||
| Low | 6.06 on 01/12/22 | 2.32 on 10/31/24 | 1.96 on 11/15/24 | ||
| High | 12.23 on 01/10/22 | 4.14 on 07/30/24 | 5.92 on 07/26/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 253,920 | 265,105 | 252,845 | ||
| Shares Outstanding, K | 34,500 | 97,465 | 113,894 | ||
| Annual Sales | 0 | 64,700,000 | 63,530,000 | ||
| Annual Net Income | -2,220,000 | -123,430,000 | -160,930,000 | ||
| Last Quarter Sales | 0 | 71,750,000 | 3,070,000 | ||
| Last Quarter Net Income | -14,255,408 | 20,240,000 | -47,680,000 | ||
| 60-Month Beta | 0.07 | 0.54 | 1.88 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 11/16/21 | 0.21 on 11/07/24 | -0.40 on 11/12/24 | ||
| Latest Earnings Date | N/A | 11/14/24 | 11/13/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||